AANEM News Express

Science News: Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy

    3/21/2023
In this single-centered study, 113 anti-NF155 and anti-CNTN1 antibody–negative chronic inflammatory demyelinating polyneuropathy (CIDP) patients were enrolled and the reactivity of sera from these patients against mouse (dorsal root ganglion) DRG and sciatic nerves was surveyed. The objective of this was to identify novel nodal autoantibodies in CIDP.

Patient Safety: Percutaneous Sharp Injuries: Post-Exposure Procedures

    3/20/2023
From the AANEM Quality and Patient Safety Committee: Many healthcare workers, including some of 64% of electrodiagnostic (EDX) physicians who may have experienced a needlestick injury, are unfamiliar with proper post-exposure procedures following percutaneous sharp injury, leading to a greater risk of blood-borne pathogen seroconversion. Read more to learn about the proper post-exposure process.

Submit an Abstract for the Myasthenia Gravis Foundation of America’s 2023 Scientific Session

    3/20/2023
The abstract submission window will officially open for the 2023 Scientific Session of the Myasthenia Gravis Foundation of America, Inc. (MGFA), on March 23, 2023. This year’s deadline is June 15, 2023.

Science News: Anti-titin Antibody Is Associated With More Frequent Hospitalization to Manage Thymoma-Associated Myasthenia Gravis

    3/3/2023
Anti-titin antibodies are anti-striational antibodies associated with thymoma-associated myasthenia gravis (MG). Anti-titin antibodies have been previously linked to severity of MG, but its relation to clinical worsening is not clear. Thus, the authors in this study aimed to evaluate whether the patients with anti-titin antibody are more frequently hospitalized to manage thymoma-associated MG than those patients without anti-titin antibody.

Science News: Virtual Charcot-Marie-Tooth Examination Score: A Validated Virtual Evaluation for People with Charcot-Marie-Tooth Disease.

    2/20/2023
The Charcot-Marie-Tooth (CMT) Examination Score Version 2 (CMTESv2) is used in clinical practice to measure impairment in patients with CMT. However, the CMTES requires an in-person visit, which may not be possible for all CMT patients. This study evaluated a virtual form of CMTES (vCMTES) as a remote clinical outcome assessment tool to measure impairment in CMT patients.

Science News: Ultrasonographic Prevalence of Ulnar Nerve Displacement at the Elbow in Young Baseball Players

    2/6/2023
Studies regarding ulnar nerve damage/displacement have been performed primarily in adults. The authors of this study assessed the ulnar nerve displacement in young baseball players.

AANEM Endorsement of the 2023 ACC Expert Consensus Decision Pathway for Cardiac Amyloidosis

    2/6/2023
AANEM has recently endorsed the 2023 American College of Cardiology (ACC) Expert Consensus Decision Pathway for Cardiac Amyloidosis which became available online Monday, January 23, 2023 with the print copy published in the JACC print issue on March 21.

The Other Side of the Fence: Tips on Conducting Peer Reviews for Biomedical Journals

    2/6/2023

Join Muscle & Nerve Editor-in-Chief Zachary Simmons and Associate Editor Peter Kang for a live webinar and Q&A, The Other Side of the Fence: Tips on Conducting Peer Reviews for Biomedical Journals.

Get Involved With AANEM & ABEM! 2023-2024 Committee Volunteers Needed

    1/24/2023
Joining a committee is a great way to get involved in AANEM, connect with colleageaus, and boost your CV. Please consider becoming an AANEM or ABEM committee volunteer! Volunteer applications are due May 15, 2023.

Test your Knowledge: Question from Lessons from the Lab Episode 1

    1/23/2023
Test your Knowledge: Question from Lessons from the Lab Episode 1